Patients to benefit from new technology that enables physicians to more accurately diagnose and locate cancers.
FORT MYERS, FLA., August 23, 2019 — Cancer & Blood Specialists of Louisville, a practice in the American Oncology Network, LLC (AON), is now offering patients a powerful new diagnostic imaging system known as positron emission tomography/computed tomography (PET/CT). This technology combines the power of hybrid imaging in one exam to enable physicians to more accurately detect and pinpoint disease—helping to improve patient outcomes.
PET/CT scans are noninvasive and painless and take about 30 minutes to perform. In addition to providing state-of-the-art imaging data, PET/CT scans offer added comfort and convenience by reducing the number of diagnostic sessions a patient must undergo.
“PET/CT scans allow for the most accurate detection of the location, size and shape of tumors and lesions," explained Jeff Esham, MBA, RT(R)(T), AON vice president of radiation oncology and radiology. "With this technology, our physicians are able to see changes within the cancer in ways that had never before been possible.”
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More